Health Effects of Arsenic

Toxicology Metals

Volumn , Issue , 2023, Pages 423-438

  García Vargas, Gonzalo G ^a   Cebrián, Mariano E ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85173807355     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9781003418917-38     Document Type: Chapter

References (205)

1. Abdo, K. M., Elwell, M. R., Montgomery, C. A., et al., Toxicol. Lett., 45, 55-56, 1989.
2. Albores, A., Cebrian, M. E., Tellez, I., and Valdez. B., Bol. Of Sanit. Panam., 86, 196-205, 1979.
3. Andelman, J. B. and Barnett, M., Feasibility study to resolve questions on the relationship of arsenic in drinking water to skin cancer. Final rep. U.S. Environmental Protection Agency, Center for Environmental Epidemiology, University of Pittsburgh, Pittsburgh, PA, 1983.
4. Aranyi, C, Bradof, J. N., O’Shea, W. J., et al., J. Toxicol. Environ. Health, 15, 163-172, 1985.
5. Armstrong, C. W., Stroube, R. B., Rubio, T., et al., Arch. Environ. Health, 39, 276-279, 1984.
6. Aschengrau, A., Zierler, S., and Cohen, A., Arch. Environ. Health, 44, 283-290, 1989.
7. ATSDR, Toxicological Profile for Arsenic, Agency for Toxic Substances and Disease Registry, Atlanta, GA, 1992.
8. Axelson, O., Dahlgren, E., Jansson, C. D., et al., Br. J. Ind. Med., 35, 8-15, 1978.
9. Bates, M. N., Smith, A. H., and Hopenhayn-Rich, C, Am. J. Epidemiol., 135, 462-476, 1992.
10. Beckett, W. S., Moore, J. L., Keogh, J. P., et al., Br. J. Ind. Med., 43, 66-67. 1986.
11. Beckman, G., Beckman, L., and Nordenson, I. Environ. Health Per sped., 19, 145-146, 1977.
12. Bencko, U. and Symon, K., Environ. Health Perspect., 19, 95-101, 1977.
13. Bencko, V., Wagner, V., Wagnerova, M., et al., J. Hyg. Epidemiol. Microbiol. Immunol., 32, 137-146, 1988.
14. Biagini, R., Rivera, M., Salvador, M., and Cordoba, S., Arch. Argent. Dermatol., 28, 151-158, 1978.
15. Blot, W. J. and Fraumeni, J. F., Jr., Lancet, 2, 142-144, 1975.
16. Bolla-Wilson, K. and Bleecker, M. L.,.J. Occup. Med., 29, 500-503, 1987.
17. Borgono, J. M. and Greiber, R., in Trace Substances Environmental Health, V, Hemphill, D.D., Ed., University of Missouri, Columbia, 13, 1972.
18. Boutwell, R. K., Agric. Food Chem., 11, 381-385, 1963.
19. Brown, L. M., Pottern, L. M., and Blot, W. J., Environ. Res., 34, 250-261, 1984.
20. Brown, R. M., Newton, D., Pickford, C. J., et al., Hum. Exp. Toxicol., 9, 41-46, 1990.
21. Burgdorf, W., Kurvink, K., and Cervenka, J., Hum. Genet., 36, 69-72, 1977.
22. Burns, L. A. and Munson, A. E.,.J. Pharmacol. Exp. Then, 265, 178-265, 1993.
23. Burns, L. A., Sikorski, E. E., Saady, J. J., et al., Toxicol. Appl. Pharmacol., 110, 157-169, 1991.
24. Butzengeiger, C. H., Klin. Wochenschr., 19, 523-527, 1940.
25. Byron, W. R., Bierbower, G. W., Brouwer, J. B., et al., Toxicol. Appl. Pharmacol., 10, 132-147, 1967.
26. Campbell, J. P. and Alvarez, J. A., Am. Fam. Physician, 40, 93-97, 1989.
27. Cebriän, M. E., Some potential problems in assessing the effects of chronic arsenic exposure in north Mexico. American Chemical Society. 194th Natl. Meet. New Orleans, (Abstr.), 1987.
28. Cebriän, M. E., Albores, A., Aguilar, M., et al. Hum. Toxicol., 2, 121-133, 1983.
29. Cebriän, M. E., Chamorro, G., and Chävez, C, Absence of teratogenic effects of low doses of arsenic in the rat, Proc. 9th Int. Congr. Pharmacology, London, 1984.
30. Cebriän, M. E., Albores, A., Connelly, J. C, et al.,.J. Biochem. Toxicol., 3, 77-86, 1988.
31. Chakraborty, A. K. and Saha, K. C, Indian J.Med. Res., 85, 326-334. 1987.
32. Chang, T. C, Hong, M. C, and Chen, C. J.. Hsueh Hui Tsa Chih, 90, 941-946, 1991.
33. Chen, C. J., Chuang, Y. C, Lin, T. M., et al.. Cancer Res., 45, 5895-5899, 1985.
34. Chen, C. J., Chuang, Y. C, You, S.-S., et al., Br.J. Cancer, 53, 399-405, 1986.
35. Chen, C. J., Wu, M.-M., Lee, S.-S., et al., Arteriosclerosis, 8, 452-460, 1988.
36. Chen, C. J. and Wang, C. J., Cancer Res., 50, 5470-5474, 1990.
37. Chen, C. J., Lai, M., Hsu, M., et al., Dose-response relationship between ingested inorganic arsenic and diabetes mellitus, 4th Annu. Meet. Int. Soc. Environ. Epidemiology, Cuernavaca, Morelos, (Abstr.). 1992a.
38. Chen, C. J., Hsu. M., Chen, S. and Wu. M.>, Increased prevalence of hypertension among residents in hyperendemic villages of chronic arsenicism in Taiwan. 4th Annu. Meet. Int. Soc. Environ. Epidemiology, Cuernavaca, Mexico, (Abstr.), 1992b.
39. Chen, C. J., Cen, C. W., Wu, M. M., and Kuo, T. L., Br. J. Cancer, 66, 882-892, 1992c.
40. Chen, G. S., Asai, T. Suzuki, Y., et al.,.J. Dermatol., 17, 599-608, 1990.
41. Chi, I.-C. and Blackwell, R. Q., Am.,J. Epidemiol., 88, 7-24, 1968.
42. Chiang, H. S., Hong. C. L., Guo, H. R., et al.,.J. Formosan Med. Assoc., 87, 1074-1080, 1988.
43. Chhuttani, P. N., Chawla, L. S., and Sharma, T. D., Neurology. 17, 269-274, 1967.
44. Cordier, S., Theriault, G., and Iturra, H., Environ. Res., 31, 311-322, 1983.
45. Cuzick, J., Sasieni, P., and Evans, S., Am. J. Epidemiol., 136, 417-421, 1992.
46. Datta, S., Talukder, G., and Sharma, A., Sei. Cult.. 52, 196-198, 1986.
47. Donofrio, P. D., Wilboum, A. J., Albers, J. W., et al.. Muscle Nerve, 10, 114-120, 1987.
48. Edmonds, M. S. and Baker, D. H., J. Anim. Sei., 63, 533-537, 1986.
49. Enterline, P. E. and Marsh, G. M., Am. J. Epidemiol., 116, 895-911, 1982.
50. Enterline, P. E., Henderson, V. L., and Marsh, G. M., Am. J. Epidemiol., 125, 929-938, 1987.
51. EPA, Health assessment document for inorganic arsenic. Final report. U.S. Environmental Protection Agency, Environmental Criteria and Assessment Office, 2-1-3-22, 9-1-9-4, EPA 600/8-83-02IF, Research Triangle Park, NC. 1984.
52. EPA, Special report on ingested inorganic arsenic. Skin Cancer; Nutritional Essentiality, U.S. Environmental Protection Agency, Office of Pesticide Programs, NTIS No. PB89-102842, Washington, D.C., 1988.
53. Espinoza, E., Bol. Epidemiol. (Mexico, D.F.), 4, 213-220, 1963.
54. Falk, H., Herbert, J. T., Edmonds, L., et al., Cancer, 47, 382-391, 1981.
55. Feldman, R. G., Niles, C. A., Kelly-Hayes, M., et al., Neurology, 29, 939-944, 1979.
56. Fennell, J. S. and Stacy, W. K., Ir. J. Med. Sei., 150, 338-339, 1981.
57. Fielder, R. J., Dale, E. A., and Williams, D., Inorganic Arsenic Compounds. Toxicity Review 16.
58. Health and Safety Executive, Her Majesty’s Stationery Office, London, 1986. Fierz, U., Dermatologica, 131, 41-48, 1965.
59. Fincher, R. M. and Koerker, R. M., Am. J. Med., 82, 549-552, 1987.
60. Foa, V., Colombi, A., Maroni, M., et al., in Occupational and Environmental Chemical Hazards, De Rosa, E., Bartolucci, G. B., and Foa, V., Eds., Halsted Press, Horwood, NY, 362, 1987.
61. Fowler, B. A., in Toxicology of Trace Elements, Goyer, R.A. and Mehlman, M.A., Eds., eds. Halstead Press, Horwood, NY, 79, 1977.
62. Fowler, A. B. and Weissburg, J. B., N. Engl. J. Med., 91, 1171-1174, 1974.
63. Franzblau, A. and Lilis, R., Arch. Environ. Health, 44, 385-390, 1989.
64. Frost, F., Harter, L., Milham, S., et al., Arch. Environ. Health, 42, 148-152, 1987.
65. Gaines, T. B., Toxicol. Appl. Pharmacol., 2, 88-99, 1960.
66. García-Salcedo, J. J., Portales, A., Blakely, E., and Díaz, R., Rev. Fac. Med. (Torreón), 1, 12-16, 1984.
67. García-Vargas, G. G., García-Rangel, A., Aguilar-Romo, M., et al., Hum. Exp. Toxicol, 10, 189-193, 1991.
68. Garcia-Vargas, G. G., Del Razo, L. M., Cebrián, M. E., et al., Hum. Exp. Toxicol, 13, 1994 (in press).
69. Gerhardt, R. E., Hudson, J. B., Rao, R. N., et al., Arch. Intern. Med., 138, 1267-1269, 1978.
70. Ghafghazy, T., Ridlington, J. W., and Fowler, B., Toxicol, Appl. Pharmacol, 55, 126-130, 1980.
71. Gherardi, R. K., Chariot, P., Vanderstigel, M., et al., Muscle Nerve, 13, 637-645, 1990.
72. Glazener, F. S., Ellis, J. G., and Johnson, P. K., Calif. Med., 109, 158-162, 1968.
73. Goebel, H. H., Schmidt, P. F., Bohl, J., et al., J. Neuropathol. Exp. Neurol, 49, 137-149, 1990.
74. Goldsmith, S. and From, A. H., N. Engl. J. Med., 303, 1096-1097, 1986.
75. Goldsmith, J. R., Deane, M., Thorn, J., et al., Water Res., 6, 1133-1136, 1972.
76. Gonsebatt, M. E., Vega, L., and Herrera, L. A., Mutat. Res., 283, 91-95, 1992.
77. Grantham, S. A. and Jones, J. F., J. Am. Water Works Assoc., 69, 653-657, 1977.
78. Grobe, J. W., Berufsdermatosen, 24, 78-84, 1976.
79. Hamamoto, E., Jpn. Med. J., 1649, 3-12, 1955 (in Japanese).
80. Harrington, J. M., Middaugh, J. P., Morse, D. L., et al., Am. J. Epidemiol, 108, 377-385, 1978.
81. Harrisson, J. W., Packman, E. W., and Abbott, D. D., Arch. Ind. Health, 17, 118-123, 1958.
82. Heyman, A., Pfeiffer, J. B., Willen, R. W., et al., N. Engl. J.Med., 254, 401-409, 1956.
83. Heywood, R. and Sortwell, R. J., Toxicol. Lett., 3, 137-144, 1979.
84. Hindmarsh, J. T. and McCurdy, R. F, Crit. Rev. Clin. Lab. Sei., 23, 315-347, 1986.
85. Hindmarsh, J. T., McLetchie, O. R., Heffeman, L. P., et al., J. Anal. Toxicol, 1, 270-276, 1977.
86. Hood, R. D., Thacker, G. T, and Patterson, B. L., Environ. Health Perspect., 19, 219-222, 1977.
87. Hood, R. D., Harrison, W. P., and Vedel, J. C, Bull. Environ. Contam. Toxicol, 29, 679-687, 1982.
88. Holmqvist, I., Acta Derm. Venereol. 31, 26-29, 44-45, 110-112, 195-204, 1951.
89. Huang, Y. Z., Qian, X. C, Wang, G. Q., et al., Chin. Med.J. (Eng.) 98, 219-222, 1985.
90. IARC, IARC monographs on the evaluation of carcinogenic risk of chemicals to humans. Suppl 7. Overall evaluations of carcinogenicity: updating ofTARC monogr. Vol. 1-42, International Agency for Research on Cancer, Lyon, France, 29, 1987.
91. Ide, C. W. and Bullough, G. R.,.J. Soc. Occup. Med., 38, 85-88, 1988.
92. Ishinishi, N., Kodama, Y., Kunitake, E., et al., Nihon Rinsho, 31, 1991-1999, 1973.
93. Jaghabir. M. T., Abdeighani, A. A., and Anderson, A. C, Bull Environ. Contam. Toxicol, 42, 289-293, 1989.
94. Jarup, L., Pershagen, G., and Wall, S., Am. J. Ind. Med., 15, 31-41, 1989.
95. Jenkins, R. B., Brain, 89, 479-498, 1966.
96. Johansen, M. G., McGowan, J. P., Tu, S. H., et al., Proc. West. Pharmacol. Soc, 27, 289-291, 1984.
97. Raise, T, Watanabe, S., and Itoh, K., Chemosphere, 14, 1327-1332, 1985.
98. Kasper, M. L., Schoenfield, L., Strom, R. L., et al., J. Am. Med. Assoc., 252, 3407-3408, 1984.
99. Kennedy, S., Rice, D. A., and Cush, P. F., Vet. Pathol, 23, 454-461, 1986.
100. Kodama, Y, Ishinishi, N., Kunitake, E., Inamasu, T., and Nobutomo, K., in Effects and Dose Response Relationship of Toxic Metals. Nordberg, G.F., Ed., Elsvier, Amsterdam, 464, 1976.
101. Kroes, R., van Logten, M. J., Berkvens, J. M., et al., Toxicology, 12, 671-679, 1974.
102. Kyle, R. A. and Pease. G. L., N. EnglJ. Med., 273, 18-23, 1965.
103. Lagerkvist, B., Linderholm, H., and Nordberg, G. F., Int. Arch. Occup. Environ. Health, 60, 361-364, 1988.
104. Landau, E. D., Thompson, D. J., Feldman, R. G., et al., Selected noncarcinogenic effects of industrial exposure to inorganic arsenic, U.S. Environmental Protection Agency, EPA 560/6-77-018, Washington, D.C., 1977.
105. Le Quesne, P. M. and McLeod, J. G., J. Neurol. Sei., 32, 437-451, 1977.
106. Lee-Feldstein, A.,.J. Occup. Med., 28, 296-302, 1986.
107. Lerman, B. B., Alt, N., and Green, D., Ann. Clin. Lab. Sei., 10, 515-517. 1980.
108. Levin-Scherz, J. K., Patrick, J. D., Weber, F. H., et al.. Ann. Emerg. Med., 16, 702-704, 1987.
109. Little, R. E., Kay, G. N., Cavender. J. B., et al., PACE, 13, 164-170, 1990.
110. Lu, F. J.. Thromb. Res., 58, 537-541, 1990.
111. Luchtrath. H.,.J. Cancer Res. Clin. Oncol. 105, 173-182. 1983.
112. Lundgren, K. D., Nord. Hyg. Tidskr., 3, 66-82, 1954.
113. Mabuchi, K., Lilienfeld, A. M., and Snell, L. M., Arch. Environ. Health, 34, 312-320, 1979.
114. Maitani, T., Saito, N., Abe, M., et al, Toxicol. Lett., 39, 63-70, 1987.
115. Matanoski, G., Landau, E., Tonascia, J., et al., Environ. Res., 25, 8-28, 1981.
116. Mazumder, D. N., Chakraborty, A. K., Ghose, A., et al., Bull. WHO, 66, 499-506, 1988.
117. Milham, S., Jr., Environ. Health Perspect., 19, 131-132, 1977.
118. Mizuta, N., Mizuta, M., Ito, F., et al., Bull. Yamaguchi Med. Sch., 4, 131-149, 1956.
119. Morris, J. S., Schmid, M., Newman, S., et al., Gastroenterology, 64, 86-94, 1974.
120. Morton, W. E. and Caron, G. A., Am. J. Ind. Med., 15, 1-5, 1989.
121. Morton, W., Starr, G., Pohl, D., et al., Cancer, 37, 2523-2532, 1976.
122. Murphy, A. U., Lyon, L. W., and Taylor, J. W., J. Neurol. Neurosurg. Psychiatry, 44, 896-900, 1981.
123. Nagymajtenyi, L., Selypes, A., and Berencsi, G., J. Appl. Toxicol., 5, 61-63, 1985.
124. Nevens, F., Fevery, J., Van Steenbergen, W., et al., J. Hepatol, 11, 80-85, 1990.
125. Nordenson, I. and Beckman, L., Hum. Hered., 41, 171-173, 1991.
126. Nordenson, I., Beckman, G., Beckman, L., et al., Hereditas, 88, 47-50, 1978.
127. Nordenson, L, Salmonsson, S., Brun, E., et al., Hum. Genet., 48, 1-6, 1979.
128. Nordstrom, S., Beckman, L., and Nordenson, I., Hereditas, 88, 43-46, 1978.
129. Nordstrom, S., Beckman, L., and Nordenson, I., Hereditas, 90, 291-296, 1979a.
130. Nordstrom, S., Beckman, L., and Nordenson, I., Hereditas, 90, 297-302, 1979b.
131. NTP, National Toxicology Program - technical report ser. no. 345. Toxicology and Carcinogenesis Studies of Roxarsone (CAS No. 121-19-7) in F344/N rats and B6C3F, mice (feed studies), U.S. Department of Health and Human Services. Research Triangle Park, NC, 1989.
132. Ohyama, S., Ishinishi, N., Hisanaga, A., et al., Appl. Organomet. Chem., 2, 333-337, 1988.
133. Okamura, K., Ota, T, Horiuchi, K., et al., Diagn. Ther. (Shinryo), 9, 240-249, 1956.
134. Ostrosky-Wegman, P., Gonsebatt, M. E., Montero, R., et al., Mutat. Res. 250, 477-482, 1991.
135. Ott, M. G., Holder, B. B., and Gordon, H. L., Arch. Environ. Health, 29, 250-255, 1974.
136. Perry, K., Bowler, R. G., Buckell, H. M., et al., Br. J. Ind. Med., 5, 6-15, 1945.
137. Pershagen, G., Am. J. Epidemiol, 122, 684-694, 1985.
138. Pershagen, G., Elinder, C. G., and Bolander, A. M., Environ. Health Perspect., 19, 133-137, 1977.
139. Pershagen, G., Bergman, F., Klominek, J., et al., Br. J. Ind. Med., 44, 454-458, 1987.
140. Petres, J., Baron, D., and Hagedorn, M., Environ. Health Perspect., 19, 223-227, 1977.
141. Pinto, S. S. and McGill, C. M., Ind. Med. Surg., 22, 281-287, 1953.
142. Pinto, S. S. and Bennett, B. M., Arch. Environ. Health, 7, 583-591, 1963.
143. Pinto, S. S., Henderson, V, and Enterline, P. E., Arch. Environ. Health, 33, 325-331, 1978.
144. Piontek, M., Hengeis, K. J., Borchard, S., et al., Dtsch. Med. Wochenschr., 114, 1653-1657, 1989 (in German).
145. Poma, K., Degraeve, N., and Susanne, C, Cytologia, 52, 445-449, 1987.
146. Prier, R. F., Nees, P. O., and Derse, P. H., Toxicol. Appl. Pharmacol. 5, 526-542, 1963.
147. Prukop, J. A. and Savage, N. L., Bull Environ. Contam. Toxicol, 36, 337-341, 1986.
148. Rencher, A. C, Carter, M. W., and McKee, D. W., J. Occup. Med, 19, 754-758, 1977.
149. Rezuke. W. N., Anderson, C, Pastuszak, W. T, Conway, S. R., and Firshein, S. I., Am.J. Hematol., 36, 291-293, 1991.
150. Rice, D. A., Kennedy, S., McMurray, C. H., et al., Res. Vet. Sei, 39, 47-51, 1985.
151. Robson, A. O. and Jelliffe, A. M., Br. Med.,J., 5351, 207-209, 1963.
152. Rosenberg, H. G., Arch. Pathol, 97, 360-365, 1974.
153. Roth, F., Ger. Med. Man., 2, 172-175, 1957.
154. Saady, J. J., Blanke, R. V, and Poklis, A., J. Anal. Toxicol, 13, 310-312, 1989.
155. Saha, K. C. and Poddar, D., Indian J. Dermatol, 31, 29-33, 1986.
156. Schaumburg, H. A., Failure to produce arsenic neurotoxicity in the rat. An experimental study, Office of Toxic Substances, No. EPA 560/11-80-022, NTIS no. PB80-209505, U.S. Environmental Protection Agency. Washington, D.C.. 1980.
157. Schrauzer, G. N. and Ishmael, D., Ann. Clin. Lab. Sei., 4, 441-447, 1974.
158. Schroeder, H. A. and Mitchener, M., Arch. Environ. Health, 23, 102-106, 1971.
159. Schroeder. H. A., Kanisawa, M., Frost, D. V., et al.,.J. Nutr. 96, 37-45, 1968.
160. Shannon. R. L. and Strayer. D. S., Hum. Toxicol, 8, 99-104. 1989.
161. Shirachi, D. Y., Tu, S. H., and McGowan, J. P., Carcinogenic effects of arsenic compounds in drinking water, Health Effects Research Laboratory, NTIS PB87-232542, EPA 600/1-87-007, U.S. Environmental Protection Agency, Cincinnati, OH, 1987.
162. Siewicki, T. C,.J. Nutr., 111,602-609, 1981.
163. Sikorski, E. E., McCay, J. A., White, K. L., Jr., et al., Fundam. Appl. Toxicol. 13, 843-858. 1989.
164. Silver, A. S. and Wainman. P. L.,.J. Am. Med. Assoc., 150, 584-585, 1952.
165. Sobel, W., Bond, G. G., Valdwin, C. L., et al.. Am. J. Ind. Med., 13, 263-270, 1988.
166. Sommers, S. C. and McManus, R. G., Cancer, 6, 347-359. 1953.
167. Southwick, J. W., Western, A. E., Beck. M. M., et al.. Community health associated with arsenic in drinking water in Millard County, Utah, Health Effects Research Laboratory, EPA-600/1-81-064, NTIS no. PB82-108374, U.S. Environmental Protection Agency, Cincinnati, OH, 1981.
168. Stevens, J. T., DiPasquale, L. C, and Farmer, J. D., Bull Environ. Contain. Toxicol, 21, 304-311, 1979.
169. Szuler, I. M., Williams, C. N., Hindmarsh, J. T., et al., Can. Med. Assoc. J., 120, 168-171, 1979.
170. Tay, C.-H. and Seah, C.-S., Med. J. Aust., 2, 424-428, 1975.
171. Telolahy, P., Javelaud, B., Cluet, J., de Ceaurriz, J., and Boudene, C, Toxicol. Lett., 66, 89-95, 1993.
172. Terada, H., Nihon Rinsho, 18, 118-127, 1960.
173. Tezuka, M., Hanioka, K., Yamanaka, K., Okada, S., Biochem. Biophys. Res. Commun., 191, 1178-1183, 1993.
174. Tinwell, H., Stephens, S. C, and Ashby, J., Environ. Health Perspect., 95, 205-210, 1991.
175. Tseng, W. P., Environ. Health Perspect., 19, 109-199, 1977.
176. Tseng, W. P., Chu, H. M., How, S. W., et al., J. Natl. Cancer Inst., 40, 453-463, 1968.
177. Tsuda, T, Nagira, T, Yamamoto, M., and Kume, Y, Ind. Health, 28, 53-62, 1990.
178. Tsutsui, T, Kawamoto, Y, Suzuki, N., et al., Toxicol. In Vitro. 5, 353-361, 1991.
179. Valentine, J. L., Reisbord, L. S., Kang, H. K., et al., Arsenic effects on population health histories. In Mills, C.F., Bremner, I., Chesters, J.K., Eds., Trace Elements in Man and Animals - TEMA 5. Proc. Fifth Int. Symp. Trace Elements in Man and Animals, Commonwealth Agricultural Bureau, Slogh, U.K., 189, 1985.
180. Vallee, B. L., Ulmer, D. D., and Wacker, W. E., Arch. Ind. Health, 21, 132-151, 1960.
181. Vig, B. K., Figueroa, M. L., Cornforth, M. N., et al., Am.J. Ind. Med., 6, 325-338, 1984.
182. Wade, H. J. and Frazer, E. S., Lancet, 1, 269-271, 1953.
183. Wagner, S. L., Maliner, J. S., Morton, W. E., et al., Arch. Dermatol, 115, 1205-1207, 1979.
184. Wahlberg, J. E. and Boman, A., Derm. Beruf. Umwelt., 34, 10-12, 1986.
185. Wall, S., Int. J. Epidemiol, 9, 73-87, 1980.
186. Watrous, R. M. and McCaughey, M. B., Ind. Med., 14, 639-646, 1945.
187. Webb, D. R., Sipes, I. G., and Carter, D. E., Toxicol. Appl. Pharmacol, 76, 96-104, 1984.
188. Webb, D. R., Wilson, S. E., and Carter, D. E., Toxicol. Appl. Pharmacol, 82, 405-416, 1986.
189. Webb, D. R., Wilson, S. E., and Carter, D. E., Am. Ind. Hyg. Assoc. J., 48, 660-667, 1987.
190. Welch, K., Higgins, I. Oh, M., et al., Arch. Environ. Health. 37, 325-335, 1982.
191. Wen, W., Lieu, T.-L., Chang, H.-J., Wuu, S. W., Yau, M.-L., and Jan, K. Y, Hum. Genet., 59, 201-201, 1981.
192. Westhoff, D. D., Samaha, R. J., and Barnes, A., Blood, 45, 241-246, 1975.
193. Willhite, C. C, Exp. Mol. Pathol, 34, 145-158, 1981.
194. Winship, K. A., Adverse Drug React. Acute Poisoning Rev., 3, 129-160, 1984.
195. Wu, M.-M., Kuo, T.-L., Hwang, Y.-H., et al., Am.J. Epidemiol, 130, 1123-1132, 1989.
196. Yamanaka, K., Hasegawa, A., Sawamura, R., et al, Biochem. Biophys. Res. Commun., 165, 43-50, 1989.
197. Yamanaka, K., Hoshino, M., Okamoto, M., et al., Biochem. Biophys. Res. Commun., 168, 58-64, 1990.
198. Yamanaka, K., Tezuka, M., Kato, K., et al., Biochem. Biophys. Res. Commun., 191, 1184-1191, 1993.
199. Yamauchi, H, Kaise, T, and Yamamura, Y, Bull. Environ. Contam. Toxicol, 36, 350-355, 1986.
200. Yeh, S., How, S. W., and Lin, C. S., Cancer, 21, 312-339, 1968.
201. Yu, H. S., Chang, K. L., Wang, C. M., and Yu, C. L., J. Dermatol. (Japan), 19, 710-714, 1992a.
202. Yu, H. S., Chen, G. S., Sheu, H. M., et al., Proc. Natl Sei. Count: Rep. China, 16, 17-22, 1992b.
203. Zaldivar, R. and Guillier, A., Zentralbl. Bakteriol. Hyg., 165, 226-234, 1977.
204. Zaldivar, R., Prunes, L., and Ghai, G., Arch. Toxicol, 47, 145-154, 1981.
205. Zierler, S., Theodore, M., and Cohen, A., Int. J. Epidemiol, 17, 589-594, 1988.